Skip to main content
. Author manuscript; available in PMC: 2017 Jul 26.
Published in final edited form as: Vaccine. 2016 May 11;34(28):3283–3290. doi: 10.1016/j.vaccine.2016.05.005

Table 1.

Demographics of Normal and Low Responder Sub-cohorts.

Cohort Dryvax cohort ACAM cohort
Demographic Category Subcategory Low Responders1 n = 19 Normal Responders1 n = 1,052 p-value Low Responders1 n = 38 Normal Responders1 n = 956 p-value
Gender % Female 5.3% 26.6% 0.04 10.5% 10.3% 1.0
Race Asian/American Indian 0.0% 7.0% 0.5 0% 4.6% 0.3
African American 10.5% 17.5% 23.7% 11.8%
White 57.9% 53.1% 73.7% 79.1%
More than one race 15.8% 8.0% 0.0% 1.5%
Other/Do not know 15.8% 14.4% 2.6% 3.0%
Ethnicity Not Hispanic 63.2% 74.6% 0.2 78.9% 81.7% 0.7
Hispanic 26.3% 21.3% 21.1% 17.2%
Do not know 10.5% 4.1% 0% 1.2%
Age (years) 19–21 15.8% 22.7% 0.7 7.9% 15.2% 0.2
22–23 36.8% 24.0% 34.2% 27.8%
24–27 26.3% 28.3% 23.7% 33.5%
28–40 21.1% 25.0% 34.2% 23.5%
Time Since Vaccination (months) 1–8 36.8% 24.0% 0.3 0% 6.5% 0.1
9–14 10.5% 25.6% 73.7% 59.5%
15–33 31.6% 25.9% 21.1% 18.8%
34–48 21.1% 24.5% 5.3% 15.2%
1

The low responder group includes all subjects with neutralizing antibody titers less than 1:32. The remaining subjects are classified as normal responders

2

Fisher’s exact test. Statistically significant differences are shown in bold font.